Pera, Marta
Larrea, Delfina
Guardia‐Laguarta, Cristina
Montesinos, Jorge
Velasco, Kevin R
Agrawal, Rishi R
Xu, Yimeng
Chan, Robin B
Di Paolo, Gilbert
Mehler, Mark F
Perumal, Geoffrey S
Macaluso, Frank P
Freyberg, Zachary Z
Acin‐Perez, Rebeca
Enriquez, Jose Antonio
Schon, Eric A
Area‐Gomez, Estela https://orcid.org/0000-0002-0962-1570
Funding for this research was provided by:
NIH (P01‐HD080642)
NIH (P01‐HD032062)
NIH (NS071571)
NIH (HD071593)
NIH (R01‐NS056049)
NIH (P50‐AG008702)
NIH (1S10OD016214‐01A1)
Fundación Alfonso Martín Escudero
Alzheimer's Drug Discovery Foundation
The Ellison Medical Foundation
The Muscular Dystrophy Association
J. Willard and Alice S. Marriott Foundation
Lucien Cote Award and Parkinson Disease Foundation (PDF‐CEI‐1364)
Lucien Cote Award and Parkinson Disease Foundation (PDF‐CEI‐1240)
The U.S. Department of Defense (W911NF‐12‐1‐9159)
The U.S. Department of Defense (W911F‐15‐1‐0169)
The U.S. Department of Defense (FA9550‐11‐C‐0028)
Alzheimer Drug Discovery Foundation
The Muscle Dystrophy Association
HHS | NIH | National Institute on Aging (K01‐AG045335)
Article History
Received: 22 February 2017
Revised: 18 August 2017
Accepted: 1 September 2017
First Online: 10 October 2017
Conflict of interest
: The authors declare that they have no conflict of interest.